Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jan 1;80(1):58-63.
doi: 10.1001/jamaneurol.2022.4133.

Effect of Irrigation Fluid Temperature on Recurrence in the Evacuation of Chronic Subdural Hematoma: A Randomized Clinical Trial

Andreas Bartley  1   2 , Jiri Bartek Jr  3   4   5 , Asgeir S Jakola  1   2 , Jimmy Sundblom  6 , Marie Fält  3 , Petter Förander  3   4 , Niklas Marklund  7 , Magnus Tisell  1   2
Affiliations
Randomized Controlled Trial

Effect of Irrigation Fluid Temperature on Recurrence in the Evacuation of Chronic Subdural Hematoma: A Randomized Clinical Trial

Andreas Bartley et al. JAMA Neurol. .

Erratum in

  • Errors in Results.
    [No authors listed] [No authors listed] JAMA Neurol. 2023 Feb 1;80(2):216. doi: 10.1001/jamaneurol.2022.4845. JAMA Neurol. 2023. PMID: 36622667 Free PMC article. No abstract available.

Abstract

Importance: The effect of a physical property of irrigation fluid (at body vs room temperature) on recurrence rate in the evacuation of chronic subdural hematoma (cSDH) needs further study.

Objective: To explore whether irrigation fluid temperature has an influence on cSDH recurrence.

Design, setting, and participants: This was a multicenter randomized clinical trial performed between March 16, 2016, and May 30, 2020. The follow-up period was 6 months. The study was conducted at 3 neurosurgical departments in Sweden. All patients older than 18 years undergoing cSDH evacuation during the study period were screened for eligibility in the study.

Interventions: The study participants were randomly assigned by 1:1 block randomization to the cSDH evacuation procedure with irrigation fluid at room temperature (RT group) or at body temperature (BT group).

Main outcomes and measures: The primary end point was recurrence requiring reoperation within 6 months. Secondary end points were mortality, health-related quality of life, and complication frequency.

Results: At 6 months after surgery, 541 patients (mean [SD] age, 75.8 [9.8] years; 395 men [73%]) had a complete follow-up according to protocol. There were 39 of 277 recurrences (14%) requiring reoperation in the RT group, compared with 16 of 264 recurrences (6%) in the BT group (odds ratio, 2.56; 95% CI, 1.38-4.66; P < .001). There were no significant differences in mortality, health-related quality of life, or complication frequency.

Conclusions and relevance: In this study, irrigation at body temperature was superior to irrigation at room temperature in terms of fewer recurrences. This is a simple, safe, and readily available technique to optimize outcome in patients with cSDH. When irrigation is used in cSDH surgery, irrigation fluid at body temperature should be considered standard of care.

Trial registration: ClincalTrials.gov Identifier: NCT02757235.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Enrollment, Randomization, and Follow-up
aOf 19 patients who were excluded immediately, 4 had an incorrect randomization procedure. This refers to 4 patients with bilateral chronic subdural hematoma undergoing surgery in 2 sessions and randomization envelopes were erroneously used for both sessions. All 4 patients were treated bilaterally according to their first randomization allocation. CT indicates computed tomography.
Figure 2.
Figure 2.. Odds Ratios and 95% CIs of Postoperative Recurrence of Chronic Subdural Hematoma for Irrigation at Room Temperature Compared With Body Temperature
Data are shown for each study center, as well for all sites combined.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis, and implications for pharmacotherapy. J Neuroinflammation. 2017;14(1):108. doi:10.1186/s12974-017-0881-y - DOI - PMC - PubMed
    1. Uno M, Toi H, Hirai S. Chronic subdural hematoma in elderly patients: is this disease benign? Neurol Med Chir (Tokyo). 2017;57(8):402-409. doi:10.2176/nmc.ra.2016-0337 - DOI - PMC - PubMed
    1. Gaist D, García Rodríguez LA, Hellfritzsch M, et al. . Association of antithrombotic drug use with subdural hematoma risk. JAMA. 2017;317(8):836-846. doi:10.1001/jama.2017.0639 - DOI - PubMed
    1. The Swedish National Board of Health . Online database of statistics. Accessed April 18, 2021. https://sdb.socialstyrelsen.se/if_ope/val.aspx
    1. Rauhala M, Luoto TM, Huhtala H, et al. . The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population. J Neurosurg. 2019;132(4):1147-1157. doi:10.3171/2018.12.JNS183035 - DOI - PubMed

Publication types

Associated data